Difference between revisions of "Team:Vilnius-Lithuania/Description"

Line 23: Line 23:
 
     <div class="modal-close"></div>
 
     <div class="modal-close"></div>
 
     <div class="modal-content">
 
     <div class="modal-content">
     <p><strong>Fig. 1</strong> Schematic overview of the SynDrop</p>
+
 
 +
<img style='max-width:100%' src='https://static.igem.org/mediawiki/2018/f/f7/T--Vilnius-Lithuania--DESCRIPTION_2_FIGURE.png'>
 +
     <p><strong>Fig. 1</strong> Fig. 1. Schematic overview of the SynDrop. Using microfluidic technology, we synthesize liposomes at a high throughput within which we encapsulate an in vitro transcription/translation system with DNA encoding a target membrane protein. In addition we encapsulate purified cellular membrane protein machinery and chaperones - they facilitate the insertion of synthesized target membrane proteins into the membrane. The system is also capable of displaying small molecules on the surface of the liposome, which makes SynDrop applicable for a novel liposome surface-display method.
 +
</p>
 
     <p></p>
 
     <p></p>
 
     <h2><var>“What I cannot create, I do not understand”</var></h2>
 
     <h2><var>“What I cannot create, I do not understand”</var></h2>

Revision as of 03:40, 18 October 2018

Description

Describe the Impossible

Cell-free systems are becoming an increasingly popular in vitro tool to study biological processes as it is accompanied by less intrinsic and extrinsic noise. Relying on fundamental concepts of synthetic biology, we apply a bottom-up forward engineering approach to create a novel cell-free system for unorthodox protein-evolution. The core of this system is cell-sized liposomes that serve as excellent artificial membrane models. By encapsulating genetic material and full in vitro protein transcription and translation systems within the liposomes, we create reliable and incredibly efficient nanofactories for the production of target proteins. Even though there are many alternative proteins that can be synthesized, our main focus is directed towards membrane proteins, which occupy approximately one third of living-cells’ genomes. Considering their significance, membrane proteins are spectacularly understudied since synthesis and thus characterization of them remain prevailing obstacles to this day. We aim to utilize liposomes as nanofactories for directed evolution of membrane proteins. Furthermore, by means of directed membrane protein-evolution, a universal exposition system will be designed in order to display any protein of interest on the surface of the liposome. This way, a system is built where a phenotype of a particular protein is expressed on the outside while containing its genotype within the liposome. To prove the concept, small antibody fragments will be displayed to create a single-chain variable fragment (scFv) library for rapid screening of any designated target.

invert